BEIJING, Dec. 21 (Xinhua) — China is at the forefront of global COVID-19 vaccine development, with most jabs undergoing phase-3 clinical trials, a health official said at a press conference Monday.

As of Dec. 2, a total of 15 vaccine candidates developed in China had entered clinical trials, of which five are in phase-3, said Zheng Zhongwei, an official with the National Health Commission, citing statistics from the World Health Organization.…

This news comes via ChinaPulse.com, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology.